Advil
An over-the-counter pain-relief brand primarily based on ibuprofen, with products for pain, fever, cold symptoms and sleep-related needs.
Last updated October 7, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Advil is a consumer-health brand whose principal active ingredient in most products is ibuprofen, a nonsteroidal anti-inflammatory drug. The brand is primarily associated with over-the-counter relief of common pain, including headaches, muscle aches, menstrual discomfort and arthritis-related pain, while some products are formulated for fever, migraine, nighttime symptoms, cold and sinus congestion, or pediatric use. Product compositions, strengths, approved indications and age restrictions vary by market and by individual product, so local labeling and professional medical advice are authoritative. The brand entered the United States in 1984 through Whitehall, then a division of Wyeth. Its launch coincided with the U.S. Food and Drug Administration's approval of ibuprofen for over-the-counter sale; ibuprofen had previously been available in the United States by prescription. Advil and Nuprin, another ibuprofen brand, were publicly announced on May 18, 1984, and Advil reached some retail stores within about a week. The brand expanded rapidly through multiple dosage forms and line extensions, including conventional tablets, capsules, liquid-filled gels, pediatric products and combination medicines. Advil became a major participant in the U.S. analgesics market and competed particularly closely with Tylenol, whose principal ingredient is acetaminophen, as well as aspirin brands such as Bayer Aspirin. By the mid-1990s, the brand was reported to hold approximately 13 percent of the multibillion-dollar U.S. over-the-counter analgesics market. Its broader range has led it to be described as a consumer-health megabrand, extending beyond a single pain-relief product into headache, cold, sinus, allergy, fever and sleep-oriented offerings. Corporate ownership changed as the consumer-health sector consolidated. Wyeth was acquired by Pfizer in 2009, bringing the brand into Pfizer's portfolio. Pfizer and GlaxoSmithKline combined their consumer-health operations in a joint venture in 2019, and that business was separated in 2022 as Haleon. Advil remains part of Haleon's consumer-health portfolio and is marketed through a range of products in the United States and selected international markets. In the United States, the portfolio has included standard Advil, Liqui-Gels, migraine, pediatric and junior-strength products, as well as combinations containing ingredients such as acetaminophen, diphenhydramine, pseudoephedrine, phenylephrine or antihistamines.
History
Advil was introduced in the United States in 1984 by Whitehall, then a division of Wyeth. The launch came at a significant regulatory moment: ibuprofen had been available by prescription in the United States since 1974, and the FDA approved its sale without a prescription in 1984. Advil and the competing brand Nuprin were announced on May 18 of that year, and Advil appeared in some retail stores within approximately one week. The brand was built around ibuprofen, a nonsteroidal anti-inflammatory drug used to reduce pain, inflammation and fever. Its early appeal came from offering consumers a widely available alternative to aspirin and acetaminophen products. Advil subsequently developed a broad range of dosage forms and specialized products, including tablets, capsules, liquid-filled gels, migraine products, pediatric formulations, nighttime products and cold, sinus and allergy combinations. Some combinations use active ingredients other than ibuprofen to address multiple symptoms; consequently, the Advil name does not identify one identical formulation across the entire portfolio. During the 1990s, Advil became one of the leading brands in the U.S. over-the-counter analgesics category. It competed with aspirin brands, especially Bayer Aspirin, and with Tylenol, an acetaminophen-based brand. Reference material describes Advil as holding about 13 percent of the U.S. over-the-counter analgesics market in the mid-1990s. The brand's range of pain, head-cold and sleep-related offerings later supported its description as a consumer-health megabrand. Advil's corporate ownership changed through a series of pharmaceutical and consumer-health transactions. Pfizer acquired Wyeth in 2009, making Pfizer the brand's corporate owner. In 2019, Pfizer and GlaxoSmithKline combined their consumer-health operations in a joint venture. That business was subsequently separated from GSK in 2022 under the Haleon name, and Advil became part of Haleon's portfolio of consumer-health brands. In early 2025, Pfizer sold its remaining interest in Haleon. The brand continues to operate as an active consumer-health label, with the U.S. range including standard ibuprofen products, Liqui-Gels, migraine and pediatric variants, nighttime products, combination pain medicines and cold, sinus and allergy products. Availability and labeling are market-specific. Consumers must follow the directions, warnings and ingredient information on the applicable local package, particularly when using combination products or products intended for children.
- 2025
Pfizer exits its Haleon stake
[1]Pfizer sold its remaining interest in Haleon, ending its direct equity position in the company that owns Advil.
- 2024
U.S. Soccer partnership announced
[1]Haleon became the official consumer-health product partner of U.S. Soccer, a partnership covering its consumer-health portfolio.
- 2022
Haleon is established
[1]The consumer-health business was spun off as Haleon, which became Advil's parent company.
- 2019
Pfizer and GSK combine consumer-health businesses
[1]Advil entered a joint consumer-health venture formed by Pfizer and GlaxoSmithKline.
- 2009
Pfizer acquires Wyeth
[1]The acquisition transferred the former Whitehall business and Advil's corporate ownership to Pfizer.
- 1990
Advil becomes a major U.S. analgesics competitor
[1]Within roughly a decade of launch, Advil had overtaken Bayer Aspirin in reported sales and was competing strongly with Tylenol.
- 1984
Advil launches in the United States
[1]Whitehall introduced Advil as an over-the-counter ibuprofen pain-relief brand, following FDA approval for nonprescription ibuprofen sales.
- 1974
Ibuprofen becomes available by prescription in the United States
[1]Ibuprofen was available in the United States by prescription before its later approval for over-the-counter sale.
Products and positioning
A mass-market over-the-counter consumer-health brand positioned around accessible, convenient relief for everyday pain and selected related symptoms.
Over-the-counter analgesic · 1984
Advil
The core Advil line consists primarily of ibuprofen products intended for temporary relief of common aches and pains and, where permitted by local labeling, fever reduction. It is available in oral dosage forms such as tablets and capsules, with strength, directions and approved uses varying by market.
Liquid-filled ibuprofen capsules
Advil Liqui-Gels
Liqui-Gels are liquid-filled capsules containing ibuprofen. The format is positioned as a convenient alternative to conventional tablets while retaining the brand's core over-the-counter pain-relief proposition. Exact dosage and labeling depend on the local product authorization.
Migraine pain relief
Advil Migraine Liqui-Gels
A migraine-oriented variant in the Advil range using a liquid-filled ibuprofen dosage form. It is marketed for temporary relief of migraine-related symptoms within the scope of its local labeling and is distinct from the brand's general-purpose pain products.
Pediatric analgesic and fever reducer
Pediatric and Children's Advil
The pediatric range includes products marketed for children and younger age groups, including Children's Advil, Flavored Children's Advil, Infant's Advil and Junior Strength Advil. Form, concentration, minimum age and dosing instructions must be checked on the specific package.
Nighttime pain-relief product
Advil PM
Advil PM combines ibuprofen with diphenhydramine in a nighttime product intended to address occasional pain together with difficulty sleeping associated with pain. It is a combination medicine and therefore carries precautions associated with both active ingredients.
Combination analgesic
Advil Dual Action with Acetaminophen
This combination product contains ibuprofen and acetaminophen, using two different pain-relief ingredients in one branded offering. Its directions, maximum daily use and safety warnings are product-specific and should be followed carefully to avoid duplicate use of either ingredient.
Cold, sinus and allergy medicines
Advil Cold, Sinus and Allergy products
The broader line includes Advil Cold and Sinus, Advil Congestion Relief, Advil Allergy Sinus, Advil Allergy and Congestion Relief, Advil Multi-Symptom Cold and Flu, and pediatric cold or allergy variants. These products combine ibuprofen with one or more decongestant or antihistamine ingredients, which differ by formulation and market.
Marketing campaigns
- 2024U.S. Soccer consumer-health partnership
United States
Haleon announced a partnership making it the official consumer-health product partner of U.S. Soccer. The relationship provided a platform for Haleon brands, including Advil, to reach sports fans.
- True Advil Stories
United States
A marketing platform built around consumer-style stories describing experiences with Advil products and everyday pain. The campaign supported the brand's effort to present product use in relatable, practical situations.
- Take Action. Take Advil.
United States
A brand slogan and advertising platform that connected Advil with taking action despite common pain, reinforcing the product's positioning as an everyday over-the-counter remedy.
- Major League Pickleball sponsorship
United States
Advil participated in sponsorship activity associated with Major League Pickleball, linking the brand with an active lifestyle and sports audience.
Brand decisions
2022
Transfer Advil to HaleonStrategyBackground
The Pfizer-GSK consumer-health joint venture was reorganized and separated from GSK as a dedicated consumer-health company.
Action taken
Haleon was established as the parent company for consumer-health brands including Advil.
Aftermath
Advil continued as part of Haleon's global consumer-health portfolio.
2019
Combine Pfizer and GSK consumer-health operationsM&ABackground
Pfizer and GlaxoSmithKline pursued a combination of their consumer-health businesses to create a larger consumer-health operation.
Action taken
The companies placed their consumer-health activities, including Advil, into a joint venture.
Aftermath
The business was later separated as Haleon in 2022, establishing Advil's current corporate home.
1984
Launch Advil as an over-the-counter ibuprofen brandProduct launchBackground
The FDA approved ibuprofen for over-the-counter sale in the United States after the ingredient had previously been prescription-only.
Action taken
Whitehall introduced Advil and made the brand available through retail channels shortly after its public announcement.
Aftermath
Advil developed into a leading U.S. analgesics brand and expanded into multiple dosage forms and symptom-oriented extensions.
- Nuprin — Nuprin was announced alongside Advil as another major branded entrant in the newly expanded over-the-counter ibuprofen category.
- Tylenol — Tylenol became one of Advil's principal competitors in the U.S. over-the-counter analgesics market.
Recent events
Advil launches #AfterMyShot Sessions campaign[3]
Reported:
Advil launched #AfterMyShot Sessions, a campaign featuring Canadian performers and celebrating the return of live performances after COVID-19 vaccination.
Advil launches Dual Action[4]
Reported:
GSK Consumer Healthcare announced the launch of Advil Dual Action, an over-the-counter product combining ibuprofen and acetaminophen. The article says it was available online and on retail shelves nationwide.
- Unconfirmed
FDA approves Advil Dual Action with Acetaminophen for OTC use[5]
Reported:
The US FDA approved Advil Dual Action with Acetaminophen as an over-the-counter pain-relief product. GSK said it plans to launch the product across the country later in 2020.
FDA approves Advil Dual Action for OTC use[6]
Reported:
GSK announced that the U.S. Food and Drug Administration approved Advil Dual Action with Acetaminophen as an over-the-counter product for pain relief in the United States. The product was stated to be available nationwide in 2020.
Sources7 sources
- 1Advilen.wikipedia.org
- 2Advil official websiteadvil.com
- 3Advil推出#AfterMyShot Sessions营销活动newswire.ca
- 4Advil推出Dual Actionprnewswire.com
- 5FDA 批准 Advil Dual Action with Acetaminophen 用于非处方销售pharmaceutical-business-review.com
- 6FDA批准Advil Dual Action作为非处方药使用prnewswire.com
- 7FDA approves GSK’s Advil Dual Action with Acetaminophen for over-the-counter use in the United States | GSKgsk.com
Cite this profile: Cite the canonical profile. /brand-wiki/advil · Editorial policy · How profiles are compiled